Imperatorin alleviated endometriosis by inhibiting the activation of PI3K/Akt/NF-κB pathway in rats
article
OA: closed
CC0
⤵ 13 in-corpus citations
AI-generated summary
Imperatorin treatment in rats reduced endometriosis by suppressing the PI3K/Akt/NF-κB signaling pathway.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AimsMost therapeutic drugs of endometriosis have been contraceptives but symptoms recur in up to 75% of cases, which makes it a presses need to try to find novel and safer therapeutic drugs. Imperatorin is a furanocoumarin existing in many plants, possessing multiple activities, including anti-inflammatory. The purpose of this study was to assess the effects and mechanisms of imperatorin in endometriosis.Main methodsEctopic endometrial volume and hematoxylin-eosin staining were used to estimate the effects of imperatorin in experimental endometriosis model rats. Potential mechanisms of imperatorin in endometriosis were systematically analyzed by network pharmacology and molecular docking. Western blotting and enzyme-linked immunosorbent assay were employed to evaluate proteins expression and cytokines levels in PI3K/Akt/NF-κB pathway.Key findingsImperatorin could significantly inhibit the growth and ameliorate the histopathological features of ectopic endometrium in experimental endometriosis rats. Network pharmacology approaches showed that imperatorin might regulate inflammatory response and cellular function via primarily affecting PI3K-Akt pathway, Endocrine resistance, Th17 cell differentiation in endometriosis. Moreover, 7 core targets (PIK3CA, AKT1, SRC, MAPK8, MAPK14, ERBB2 and CCND1) resulted from the intersection of KEGG and PPI network topological analysis were used to dock with imperatorin, which indicated that imperatorin could preferably fit in the binding pocket of the above target proteins, except for CCND1. Lastly, imperatorin markedly inhibited the activation of PI3K/Akt/NF-κB pathway via suppressing the phosphorylation levels of PI3K, Akt and p65 in the ectopic endometrium tissue.SignificanceOur findings revealed that imperatorin is a significant multi-target natural active ingredient for treatment endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (54)
- Ameliorative Effects of Quercetin and Metformin and Their Combination Against Experimental Endometriosis in Rats via openalex
- Clinical diagnosis of endometriosis: a call to action via openalex
- Crocin improves endometriosis by inhibiting cell proliferation and the release of inflammatory factors via openalex
- Curcumin and Endometriosis via openalex
- Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF‐κB signaling pathway via openalex
- Differential regulation of Akt phosphorylation in endometriosis via openalex
- Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model via openalex
- Endometriosis and Infertility via openalex
- Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Lipopolysaccharide promotes early endometrial-peritoneal interactions in a mouse model of endometriosis via openalex
- Natural products: Potential lead compounds for the treatment of endometriosis via openalex
- New developments in the medical treatment of endometriosis via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Novel dietary supplement association reduces symptoms in endometriosis patients via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage via openalex
- QS ENDO Real – A Study by the German Endometriosis Research Foundation (SEF) on the Reality of Care for Patients with Endometriosis in Germany, Austria and Switzerland via openalex
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex
- Sulforaphane Attenuates Endometriosis in Rat Models Through Inhibiting PI3K/Akt Signaling Pathway via openalex
- The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression via openalex
- The role of TGF-β in the pathophysiology of peritoneal endometriosis via openalex
- Viburnum opulus L.: A remedy for the treatment of endometriosis demonstrated by rat model of surgically-induced endometriosis via openalex
- W2950764390 via openalex
- W2973388422 via openalex
- W3015361255 via openalex
- W3019838847 via openalex
- W4234160457 via openalex
- W4247319216 via openalex
- W6640754151 via openalex
- W1593555249 via openalex
- W6683305549 via openalex
- W1971465028 via openalex
- W1993904537 via openalex
- W2030219843 via openalex
- W2033122881 via openalex
- W2094583219 via openalex
- W2124679671 via openalex
- W2134967712 via openalex
- W2155142785 via openalex
- W2156754327 via openalex
- W2163315477 via openalex
- W2346020725 via openalex
- W2407564830 via openalex
- W2474747771 via openalex
- W2537623931 via openalex
- W2603538925 via openalex
- W2720897370 via openalex
- W2763239767 via openalex
- W2767268934 via openalex
- W2792504918 via openalex
- W2898391595 via openalex
- W2901052686 via openalex
- W2946412700 via openalex
Cited by (14)
- Evidence for KISS-1 nuclear translocation and PI3K/AKT signaling in the ultrastructurally and morphometrically analyzed human endometriosis 2026
- Immune-epigenetic-metabolic crosstalk: attempting to unravel the multidimensional mechanisms of immune evasion in endometriosis 2026
- Integrated GNPS, semi-preparative HPLC, and network pharmacology reveal active ingredients and potential machenisms of Paeonia suffruticosa Andr. leaves in treating endometriosis with anxiety/depression 2025
- Therapeutic effects and mechanisms of alcohol extracts from Polygala fallax Hemsl on endometriosis in rats 2025
- WITHDRAWN: The main active monomer of Dan'e-fukang soft extract, liquiritin, inhibits the inflammation and invasion of endometrial ectopic stromal cells through down-regulation of CCL2 2025
- Exploration into the Mechanism of Yiyi Baijiang Decoction Attenuating Chronic Pelvic Inflammation Based on Network Pharmacology and Experimental Verification 2024
- Identifying Potential Bioactive Components and Targets of Shaofuzhuyu Decoction in Treating Endometriosis Using serum Pharmacochemistry and Network Pharmacology 2024
- Exploring the role of Chinese herbal medicine in the long-term management of postoperative ovarian endometriotic cysts: a systematic review and meta-analysis 2024
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Effect and mechanisms of kaempferol against endometriosis based on network pharmacology and in vitro experiments 2022
- Zearalenone affects the growth of endometriosis via estrogen signaling and inflammatory pathways 2022
- Progranulin promotes proliferation, migration and invasion via the PI3K/Akt signalling pathway in a model of endometriosis 2022
- Additional file 1 of Effect and mechanisms of kaempferol against endometriosis based on network pharmacology and in vitro experiments 2022
- Additional file 1 of Effect and mechanisms of kaempferol against endometriosis based on network pharmacology and in vitro experiments 2022
Source provenance
- europepmc
- last seen: 2026-07-28T06:14:09.330459+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:49.034193+00:00
License: CC0
· commercial use OK